|
BASEL, Switzerland (AP) -- Novartis AG said Monday that a U.S. court has halted Teva Pharmaceutical Industries Ltd.'s sale of a generic version herpes treatment. Swiss-based pharmaceutical giant said the injunction by the U.S. Court of Appeals for the Federal Circuit was issued on Friday, two days after a district court in New Jersey denied a motion to stop Israel's Teva from marketing its version Novartis' Famvir. The injunction requires Teva to submit a response by Tuesday, Novartis said in a statement. Novartis shares fell 0.9 percent to 62.95 Swiss francs ($52.98) in Zurich trading.
|